The effectiveness results were as follows:
The extracorporeal group had a survival rate, at 1 year of age, of 68% versus 41% in the conventional group.
The respective values for the number of survivors without severe disability were, 61 in the extracorporeal group versus 36 in the conventional group;
the number of survivors with no disability, 49 in the extracorporeal group versus 32 in the conventional group;
the number of survivors with impairment or disability, 17 in the extracorporeal group versus 10 in the conventional group.
The readmission rate for the survivors was 51% in the control group versus 35% in the intervention group.